Fatty acid composition of light lamb meat from Leccese and Comisana dairy breeds as affected by slaughter age

Forty lambs of two Italian dairy breeds were used to study the effects of slaughter age and breed on meat fatty acid composition. Lambs were subdivided into four groups (n. 10) according to a factorial scheme of two breeds (Leccese and Comisana). ×. two slaughter ages (45 and 60 days). The lambs were fed maternal milk supplemented with hay and concentrate from the 30th day to the slaughter. Leccese lambs at 45 days exhibited a FA profile more compatible to nutritional requirements for human health. They displayed a lower SFA proportion, a higher UFA/SFA and MUFA/SFA ratios than Comisana. The delay of slaughtering age at 60 days improved FA composition in Comisana lambs which had lower SFA content, AI and TI indexes and higher UFA/SFA and MUFA/SFA ratios and n-3 PUFA content than in Leccese. In both the breeds, the slaughter age at 60 days improved the CLA content

Constitutive heterochromatin distribution in pig (Sus scrofa) chromosomes

Summary Constitutive heterochromatin (HC = C-banding) distribution was studied in pig (Sus 5crofa) chromosomes from 20 animals belonging to Cinta Senese and Calabrese breeds raised in southern Italy. The use of CBG-banding, sequential GBG/CBA-banding and sequential GBGA/g- NOR/CBA-banding techniques allowed more detailed characterization of C-banding patterns in pig chromosomes (SSC). The following features were noticed: (a) all autosomes and the X-chromosome showed centromeric C-positive bands; (b) the entire q-arm and proximal part of the p-arm y chromosome were C-positive: (c) clear interstitial C-positive bands were noticed in SSC1q17, SSC3p14 and SSC16q21; (d) the nucleolus organizer (NO) chromosome 10 showed two distinct HC-blocks very far apart in both arms with large, polymorphic (different size) NORs between the chromosome pair, while NO-chromosome 8 showed only one C-positive band (the smallest) in the q-arms; (e) C-band polymorphism was observed between and within chromosome pairs also in relat..

The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma

Treatment with PARP inhibitors (PARPi) is primarily effective against high-grade serous ovarian cancers (HGSOC) with BRCA1/2 mutations or other deficiencies in homologous recombination (HR) repair mechanisms. However, resistance to PARPi frequently develops, mostly as a result of BRCA1/2 reversion mutations. The tumour suppressor CCDC6 is involved in HR repair by regulating the PP4c phosphatase activity on γH2AX. In this work, we reported that in ovarian cancer cells, a physical or functional loss of CCDC6 results synthetic lethal with the PARP-inhibitors drugs, by affecting the HR repair. We also unravelled a role for CCDC6 as predictive marker of PARPi sensitivity in ovarian cancer, and the impact of CCDC6 downregulation in overcoming PARPi resistance in these tumours

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)

Brentuximab vedotin (BV) shows a high overall response rate (ORR) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) after autologous transplant (ASCT). The aim of this multicenter study, conducted in nine Hematology Departments of Rete Ematologica Pugliese, was to retrospectively evaluate the efficacy and safety of BV as salvage therapy and as bridge regimen to ASCT or allogeneic transplant (alloSCT) in R/R HL patients. Seventy patients received BV. Forty-five patients (64%) were treated with BV as bridge to transplant:16 (23%) patients as bridge to ASCT and 29 (41%) as bridge to alloSCT. Twenty-five patients (36%), not eligible for transplant, received BV as salvage treatment. The ORR was 59% (CR 26%). The ORR in transplant naïve patients was 75% (CR 31%). In patients treated with BV as bridge to alloSCT, the ORR was 62% (CR 24%). In a multivariate analysis, the ORR was lower in refractory patients (p < 0.005). The 2y-OS was 70%. The median PFS was 17 months. Ten of the 16 (63%) naïve-transplant patients received ASCT, with 50% in CR before ASCT. In the 29 patients treated with BV as bridge to alloSCT, 28 (97%) proceeded to alloSCT with 25% in CR prior to alloSCT. The most common adverse events were peripheral neuropathy (50%), neutropenia (29%) and anemia (12%). These data suggest that BV is well tolerated and very effective in R/R HL, producing a substantial level of CR. BV may also be a key therapeutic agent to achieve good disease control before transplant, improving post- transplant outcomes, also in refractory and heavily pretreated patients, without significant overlapping toxicities with prior therapies

The Zero Emissions Commitment and climate stabilization

How do we halt global warming? Reaching net zero carbon dioxide (CO2) emissions is understood to be a key milestone on the path to a safer planet. But how confident are we that when we stop carbon emissions, we also stop global warming? The Zero Emissions Commitment (ZEC) quantifies how much warming or cooling we can expect following a complete cessation of anthropogenic CO2 emissions. To date, the best estimate by the Intergovernmental Panel on Climate Change (IPCC) Sixth Assessment Report is zero change, though with substantial uncertainty. In this article, we present an overview of the changes expected in major Earth system processes after net zero and their potential impact on global surface temperature, providing an outlook toward building a more confident assessment of ZEC in the decades to come. We propose a structure to guide research into ZEC and associated changes in the climate, separating the impacts expected over decades, centuries, and millennia. As we look ahead at the century billed to mark the end of net anthropogenic CO2 emissions, we ask: what is the prospect of a stable climate in a post-net zero world

SeaConditions: a web and mobile service for safer professional and recreational activities in the Mediterranean Sea

Abstract. Reliable and timely information on the environmental conditions at sea is key to the safety of professional and recreational users as well as to the optimal execution of their activities. The possibility of users obtaining environmental information in due time and with adequate accuracy in the marine and coastal environment is defined as sea situational awareness (SSA). Without adequate information on the environmental meteorological and oceanographic conditions, users have a limited capacity to respond, which has led to loss of lives and to large environmental disasters with enormous consequent damage to the economy, society and ecosystems. Within the framework of the TESSA project, new SSA services for the Mediterranean Sea have been developed. In this paper we present SeaConditions, which is a web and mobile application for the provision of meteorological and oceanographic observation and forecasting products. Model forecasts and satellite products from operational services, such as ECMWF and CMEMS, can be visualized in SeaConditions. In addition, layers of information related to bathymetry, sea level and ocean-colour data (chl a and water transparency) are displayed. Ocean forecasts at high spatial resolutions are included in the version of SeaConditions presented here. SeaConditions provides a user-friendly experience with a fluid zoom capability, facilitating the appropriate display of data with different levels of detail. SeaConditions is a single point of access to interactive maps from different geophysical fields, providing high-quality information based on advanced oceanographic models. The SeaConditions services are available through both web and mobile applications. The web application is available at www.sea-conditions.com and is accessible and compatible with present-day browsers. Interoperability with GIS software is implemented. User feedback has been collected and taken into account in order to improve the service. The SeaConditions iOS and Android apps have been downloaded by more than 105 000 users to date (May 2016), and more than 100 000 users have visited the web version

RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases

No abstract available

RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases

No abstract available